Skip to main content

Table 1 Clinical and lifestyle characteristics of the pancreatic cancer patients and controls included in this study

From: Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts

Variable

Finnish cohort

Iranian cohort

PDAC

HC

p valuec

PDAC

HC

p valuec

Samples included (n)

33

35

 

50

34

 

Agea (years)

69 ± 8

65.0 ± 10.3

0.109

62.36 ± 11.9

40.4 ± 11.6

 < 0.001

Sex (% female)

57.6

60.0

0.839

40.0

52.9

0.242

BMIa (kg/m2)

24.8 ± 4.2

26.6 ± 4.4

0.096

NA

NA

 

Biliary stent (%)

67.7

0

 

0

0

 

Neoadjuvant treatment (%)

36.4

0

 

0

0

 

Smokersb (%)

40.0

28.6

0.332

32.7

11.8

0.011

Alcohol use (%)

63.0

51.4

0.364

3.8

8.8

0.359

Previous cancer

21.2

0

 

6.0

0

 
  1. aGiven as mean ± standard deviation
  2. bIncluding ex-smokers with smoking cessation < 10 years ago
  3. cSignificant (< 0.05) p values are bolded. Significance was tested by Student’s t-test for continuous variables and Wald H0 test for categorical variables. BMI, body mass index; HC, healthy control; NA, not available; PDAC, pancreatic ductal adenocarcinoma